<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene E484A;N501Y literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.E484A;N501Y</span> literature reference collection</h1>
<div class="effect_section"><h2 id="pharmaceutical_effectiveness">Pharmaceutical effectiveness</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> 3rd exposure to antigen by Delta (B.1.617.2) (n=24) breakthrough increases the number of memory B cells that produce antibodies with comparable potency and breadth to a 3rd mRNA vaccine dose in individuals aged 21 â€“63 years, median age=30 years. Data collected 5.5 months after 2nd vaccination.<br/> (<a href="https://doi.org/10.1101/2022.08.11.503601" class="lit_link">Wang et al. (2022)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="vaccine_efficacy">Vaccine efficacy</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Pseudotyped virus neutralization demonstrated that Bi-Nab35B5-47D10 can efficiently neutralize VBMs including Alpha (B.1.1.7), Beta (B.1.351) and Kappa  (B.1.617.1) and VOCs including Delta (B.1.617.2).<br/> (<a href="https://doi.org/10.1101/2022.05.11.491588" class="lit_link">Yuan et al. (2022)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> In a Belgian study including 1,433,135 persons (vaccinated between July 2021 to April 2022) infection-acquired immunity offered additional protection  against symptomatic infection with Omicron in vaccinated persons compared to those without previous infection, when the infection was up to one year previous.<br/> (<a href="https://doi.org/10.1101/2022.05.09.22274623" class="lit_link">Braeye et al. (2022)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> In sera from 17 sero-positive blood donors, and 18 months post-infection (May 2020) sera from 17 health  care workers in Sweden, a 40x drop in neutralization by Omicron (B.1.1.529) pseudotyped lentivirus  was observed in HEK293T cells using the First WHO International Standard (20/136). Median IC50 reduction was ~6x for the blood donors, and ~4.5x for the health care workers.<br/> (<a href="https://drive.google.com/file/d/1CuxmNYj5cpIuxWXhjjVmuDqntxXwlfXQ/view" class="lit_link">Sheward et al. (2021)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
